- Home
- News
- us virgislands
- bone generation
Bone Generation Articles & Analysis
12 news found
P-15L Bone Graft is based on a small biomimetic peptide (P-15) technology developed by Cerapedics to support bone growth, and is designed to be used as a substitute for autologous bone. In 2015, the company’s first-generation bone graft became the first bone graft to be approved for use in ...
The data demonstrate that elderly patients in Denmark treated with i-FACTOR bone graft plus local bone had a statistically significantly higher fusion rate compared to allograft plus local bone. ...
Cerapedics Inc., an ortho-biologics company dedicated to enhancing the science of bone repair, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for its investigational P-15L Bone Graft for the treatment of degenerative disc disease (DDD). ...
BIOSPHERE® FLEX SP EXTREMITIES is a third-generation bioactive glass bone graft solution. Specifically developed to maximize the bone healing potential of bioactive glass. Utilizing the well-known and trusted 45S5 bioactive glass composition that has been proven to be an effective bone graft material. FLEX SP EXTREMITIES is a ...
Synergy Biomedical, LLC, a developer of innovative biomaterial products, today announced the launching of BIOSPHERE® MIS II, Next Generation Minimally Invasive Bone Graft Delivery System. Synergy continues to add solutions for surgeons with new innovative biomaterial products to an already successful portfolio. Leveraging off the proven success of the ...
Synergy Biomedical, LLC, a developer of innovative bone graft products for spine and orthopedic surgery, announced the publication of a basic science study describing the findings and scientific strategies of controlling the bone formation response of bioactive glass. ...
MiQ will combine their automation experience with NuShores’ material sciences experience in bone regeneration scaffolds to develop multi-generational manufacturing solutions and a roadmap of the full expression of the factory in a box concept for future investment. ...
The 3D GraftRasp System is the only device to receive FDA clearance that allows for both decortication of bone and the delivery of autograft, allograft or synthetic bone graft. ...
Cerapedics, a private ortho-biologics company, today announced the Health Canada approval of the company’s next-generation bone graft called i-FACTOR+ Matrix, making it the first market to approve the commercial launch of this product. ...
The transplanted bone contains stem cells necessary to generate new bone. However, there is a caveat to this approach— as we get older the grafts become less effective because the stem cells in our bones are less efficient at making new bone. The end result is little or no bone healing. ...
Pinnacle Spine Group, LLC, a developer of innovative spinal fusion solutions engineered to deliver optimal bone graft volume and graft-to-endplate contact, today announced the launch of its InFill® V2 Lateral Interbody Device. ...
The company also intends to investigate the use of WNT3A in additional bone and other tissue repair applications. Ankasa has obtained multiple proofs of efficacy for WNT3A in various models of bone repair in animals. If approved for commercial use, it could serve as an alternative to the protein BMP-2, a protein that is used commercially to induce ...